Breast cancer drug ‘found to reduce risk of disease progression’

(PA)

The trial of a new drug to treat a form of breast cancer has been hailed as “groundbreaking”, with results said to show a strong trend towards improved overall survival.

Pharmaceutical company AstraZeneca said Enhertu demonstrated a 72% reduction in the risk of disease progression or death in women with HER2-positive metastatic breast cancer compared to a different medicine.